Avalo Therapeutics Inc
AVTX
$16.57-0.72%
End of day · as of Sep 21, 2026, 1:01 AM ET
Mkt cap
$51.54M
EV/Sales
604.8
P/E ratio
N/A
FY2025 Revenue
$59,000
EPS (TTM)
$-4.41
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-132642.37%
Beta
0.71
Div yield
N/A
Sector
Healthcare
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Latest reported AVTX revenue for 2025-12-31 was $59.0K. Net income was -$78.3M. Revenue was down 86.6% from 2024-12-31 to 2025-12-31. AVTX currently screens at market cap $51.5M.
Use this AVTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AVTX income, balance, and cash tables.
Avalo Therapeutics Inc (AVTX) is a biotechnology company in the Healthcare sector.
Latest cached Avalo Therapeutics Inc (AVTX) revenue for Dec 31, 2025 was $59.0K. Net income was -$78.3M. Statements: https://lician.com/financials/avtx
Avalo Therapeutics Inc (AVTX) market capitalization is $51.5M on the latest cached snapshot.
Avalo Therapeutics Inc (AVTX) cached previous close $16.69; day range $16.34 – $16.93; volume 3,227,265. Session quote: https://lician.com/quote/avtx
Avalo Therapeutics Inc (AVTX) latest cached earnings event is "AVTX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AVTX filing is 8-K · Jun 23, 2026. Filings: https://lician.com/sec/avtx